Utah Medical Products (UTMD) Net Cash Flow (2010 - 2026)

Utah Medical Products' Net Cash Flow history runs 17 years deep, the most recent figure standing at $1.9 million for Q1 2026.

• On a quarterly basis, Net Cash Flow rose 4333.33% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $3.8 million, a 136.32% increase from a year earlier, with the FY2025 full-year figure at $2.0 million, up 121.52% from the prior year.
• Net Cash Flow grew to $1.9 million in Q1 2026 per UTMD's latest filing, from $1.4 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $5.8 million in Q1 2023 and bottomed at -$4.8 million in Q4 2024.
• The 5-year median for Net Cash Flow is $1.9 million (2026), against an average of $1.6 million.
• Across the five-year window, Net Cash Flow sank 226.79% in 2024 and jumped 4333.33% in 2026, its largest moves.
• Year by year, Net Cash Flow stood at $4.7 million in 2022, then fell by 11.67% to $4.2 million in 2023, then slumped by 215.54% to -$4.8 million in 2024, then soared by 128.99% to $1.4 million in 2025, then jumped by 33.29% to $1.9 million in 2026.
• Per Business Quant, the three latest UTMD Net Cash Flow figures stand at $1.9 million (Q1 2026), $1.4 million (Q4 2025), and $2.2 million (Q3 2025).